Who is the sponsor?
Who are the patients?
Patients who have completed participation in certain other LucentisTM clinical studies and meet the eligibility criteria.
How long are the eligible patients enrollment?
When did participation agreement start at our site?
What is the enrollment goal for the sponsor?
Is the enrollment still open?
No. This study is now closed.
What is this study investigating?
Phase III open-label extension study, which allows eligible patients who have completed participation in certain other LucentisTM clinical studies to continue to receive the investigational drug.
How is the treatment administered?